Citation Impact
Citing Papers
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
2012
Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
2009 Standout
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
2002
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
2009
ESUR prostate MR guidelines 2012
2012 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
2004 Standout
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
2002
The relationship between prognostic and predictive factors in the management of breast cancer
1998
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
2004
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
A prospective randomised study of total laparoscopic hysterectomy, laparoscopically assisted vaginal hysterectomy and non-descent vaginal hysterectomy for the treatment of benign diseases of the uterus
2010
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Are Antibiotics Necessary in Hip Arthroplasty With Asymptomatic Bacteriuria? Seeding Risk With/Without Treatment
2013
Endometrial Carcinomas
2011
The tor pathway: a target for cancer therapy
2004 Standout
Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases
2002 Standout
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects
2001
Marine natural products
1990 Standout
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
2001
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Prospective comparison of tissue trauma after laparoscopic hysterectomy types with retroperitoneal lateral transsection of uterine vessels using ligasure and abdominal hysterectomy
2007
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
2005 Standout
Mutations in exons 5-8 of thep53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma
1999
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Enzymatic rationale and preclinical support for a potent protein kinase Cβ inhibitor in cancer therapy
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Dynamic magnetic resonance imaging of tumor perfusion
2004
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Human papillomavirus and cervical cancer
2007 Standout
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
The preterm parturition syndrome
2006 Standout
A systematic review of humoral immune responses against tumor antigens
2009
Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers
2003
p53 in health and disease
2007 Standout
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial
2009
Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology
2001
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
p53 mutation heterogeneity in cancer
2005
Cancer immunotherapy comes of age
2011 StandoutNature
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
p16 Modulates VEGF Expression via Its Interaction With HIF-1α in Breast Cancer Cells
2010
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
2000
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
2007
Fetal growth restriction is associated with increased apoptosis in the chorionic trophoblast cells of human fetal membranes
2004
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Prospective Study of Eukaryotic Initiation Factor 4E Protein Elevation and Breast Cancer Outcome
2002
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Current status of surgical and nonsurgical management of ectopic pregnancy
1997
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Tumor Angiogenesis
2008 Standout
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
2000
Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and genetics
2004
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer
2000
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β
2000
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
2000
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer
2005
Molecular-Targeted Antitumor Agents: The Saururus cernuus Dineolignans Manassantin B and 4-O-Demethylmanassantin B Are Potent Inhibitors of Hypoxia-Activated HIF-1
2004
Laurenditerpenol, a New Diterpene from the Tropical Marine Alga Laurencia intricata that Potently Inhibits HIF-1 Mediated Hypoxic Signaling in Breast Tumor Cells
2004
Prosthetic Joint Infection
2014 Standout
Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
2001
p53 Antibodies in the sera of patients with various types of cancer: a review.
2000
X-Tile
2004 Standout
Surgical approach to hysterectomy for benign gynaecological disease
2015 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer
2006
Works of E Kučera being referenced
Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple.
2001
Late Hematogenous Infection of Prosthetic Joint
2008
Amplification and Expression of the c-erbB-2 Oncogene in Müllerian-Derived Genital-Tract Tumors
1998
Genetic alterations in endometrial hyperplasia and cancer
2002
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients
1999
Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival
1997
Accuracy of Intraoperative Frozen-Section Diagnosis in Stage I Endometrial Adenocarcinoma
2000
Bcl-2 expression as a novel immunohistochemical marker for ruptured tubal ectopic pregnancy
2001
[Clinical comparison of laparoscopy-assisted vaginal hysterectomy (LAVH) and total laparoscopy hysterectomy (TLH) in women with benign disease of uterus--a prospective randomized study].
2006
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
1999
Humoral p53 antibody response is a prognostic parameter in ovarian cancer.
1999
Fertility after operations of extrauterine pregnancy.
1969
Prostate specific antigen (PSA) in breast and ovarian cancer.
1998